Want to see QUCY full AI Analyst Report?
QUCY Stock Chart & Stats
$1.16
-$0.30(-6.42%)
At close: 4:00 PM EST
$1.16
-$0.30(-6.42%)
Day’s Range― - ―
52-Week Range$0.30 - $4.93
Previous CloseN/A
VolumeN/A
Average Volume (3M)350.23K
Market Cap
$35.74M
Enterprise Value$19.46M
Total Cash (Recent Filing)$4.45M
Total Debt (Recent Filing)$126.79K
Price to Earnings (P/E)―
Beta1.39
Next Earnings
Sep 09, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.43
Shares Outstanding22,767,254
10 Day Avg. Volume923,862
30 Day Avg. Volume350,228
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)7.48
Price to Sales (P/S)8.93
P/FCF Ratio-0.40
Enterprise Value/Market Cap0.54
Enterprise Value/Revenue67.86
Enterprise Value/Gross Profit67.86
Enterprise Value/Ebitda-2.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.03
Revenue Forecast (FY)$917.75K
Bulls Say, Bears Say
Bulls Say
Improving Gross MarginsSustained expansion of gross margin to ~73% signals materially improved unit economics and product mix. This structural margin strength creates operating leverage as revenue scales, increasing the prospect of moving toward sustainable profitability if fixed costs are controlled.
Debt-free Capital Infusion From Warrant ExercisesA >$15M non-debt capital infusion and elimination of outstanding warrants materially strengthen short-term liquidity and simplify the cap table. This improves runway for R&D, commercialization and selective M&A without adding leverage, reducing structural liquidity risk.
Exclusive IP License For Quantum Photonic AntennasAn exclusive license to core quantum photonic antenna tech creates a differentiated technology layer for its autonomous defense platform. Patent-protected, exclusive rights and a prototype delivery timetable bolster long-term competitive advantage in growing defense drone and counter-UAS markets.
Bears Say
Persistent Cash BurnConsistent, sizable negative operating and free cash flow erodes runway and forces reliance on external funding. Structural cash burn constrains sustained R&D and commercialization investments and increases dilution or financing risk unless revenue or margins improve substantially.
Deteriorated Balance-sheet ResilienceA sharp rise in leverage versus a shrinking equity base reduces financial flexibility and increases vulnerability to shocks. With a thin equity cushion, the company faces higher financing costs and limited ability to absorb setbacks during a multi-quarter commercialization and integration period.
Volatile Revenue And Persistent LossesSignificant, recurring net losses and a meaningful 2025 revenue decline indicate inconsistent product-market fit and scaling challenges. Persistent top-line volatility undermines ability to leverage improving gross margins into sustained operating profitability over the medium term.
Quantum Cyber News
QUCY FAQ
What was Quantum Cyber’s price range in the past 12 months?
Quantum Cyber lowest stock price was $0.30 and its highest was $4.93 in the past 12 months.
What is Quantum Cyber’s market cap?
Quantum Cyber’s market cap is $35.74M.
When is Quantum Cyber’s upcoming earnings report date?
Quantum Cyber’s upcoming earnings report date is Sep 09, 2026 which is in 70 days.
How were Quantum Cyber’s earnings last quarter?
Quantum Cyber released its earnings results on Apr 14, 2026. The company reported -$0.431 earnings per share for the quarter, beating the consensus estimate of -$1.01 by $0.579.
Is Quantum Cyber overvalued?
According to Wall Street analysts Quantum Cyber’s price is currently Overvalued.
Does Quantum Cyber pay dividends?
Quantum Cyber does not currently pay dividends.
What is Quantum Cyber’s EPS estimate?
Quantum Cyber’s EPS estimate is -0.02.
How many shares outstanding does Quantum Cyber have?
Quantum Cyber has 22,767,254 shares outstanding.
What happened to Quantum Cyber’s price movement after its last earnings report?
Quantum Cyber reported an EPS of -$0.431 in its last earnings report, beating expectations of -$1.01. Following the earnings report the stock price went up 20.198%.
Which hedge fund is a major shareholder of Quantum Cyber?
Currently, no hedge funds are holding shares in QUCY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Quantum Cyber Stock Smart Score
Company Description
Quantum Cyber
Mainz Biomed N.V. is a specialized enterprise in the field of molecular genetics, primarily focused on cancer diagnostics. The company's core mission involves developing and producing market-ready molecular genetic diagnostic solutions specifically engineered for life-threatening medical conditions. Beyond creation, it actively engages in the global commercialization of its product portfolio, reaching markets across Europe, the United States, and other international territories. This firm was established on March 8, 2021, and maintains its headquarters in Mainz, Germany.
Technical Analysis
―
ENDRA Life Sciences
―
Intelligent Bio Solutions
―
iSpecimen
―
BioNexus Gene Lab Corp
―
Ownership Overview
8.84% Insiders
<0.01% Mutual Funds
0.07% Other Institutional Investors
91.08% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---